Published in:
01-04-2012
Discrepancy in Diagnosis and Treatment of Post-traumatic Stress Disorder (PTSD): Treatment for the Wrong Reason
Authors:
Ellen C. Meltzer, MD, MSc, Tali Averbuch, MPP, Jeffrey H. Samet, MD, MA, MPH, Richard Saitz, MD, MPH, Khelda Jabbar, MD, Christine Lloyd-Travaglini, MPH, Jane M. Liebschutz, MD, MPH
Published in:
The Journal of Behavioral Health Services & Research
|
Issue 2/2012
Login to get access
Abstract
In primary care (PC), patients with post-traumatic stress disorder (PTSD) are often undiagnosed. To determine variables associated with treatment, this cross-sectional study assessed 592 adult patients for PTSD. Electronic medical record (EMR) review of the prior 12 months assessed mental health (MH) diagnoses and MH treatments [selective serotonin reuptake inhibitor (SSRI) and/or ≥1 visit with MH professional]. Of 133 adults with PTSD, half (49%; 66/133) received an SSRI (18%), a visit with MH professional (14%), or both (17%). Of those treated, 88% (58/66) had an EMR MH diagnosis, the majority (71%; 47/66) depression and (18%; 12/66) PTSD. The odds of receiving MH treatment were increased 8.2 times (95% CI 3.1–21.5) for patients with an EMR MH diagnosis. Nearly 50% of patients with PTSD received MH treatment, yet few had this diagnosis documented. Treatment was likely due to overlap in the management of PTSD and other mental illnesses.